麦格理发表研究报告,维他奶(00345.HK) 2026财年下半年收入按年持平,纯利则按年增长60%,期内中国内地业务表现持续改善,收入跌幅由上半财年的9%收窄至3%;澳洲业务经调整后经营亏损则收窄至4,000万元。麦格理维持维他奶的“跑赢大市”评级,目标价由7.4元上调至7.9元,预期严格成本管理及渠道扩张将支撑未来盈利增长。计及包装材料成本压力,该行将2027及2028财年纯利预测分别下调...
Source Link麦格理发表研究报告,维他奶(00345.HK) 2026财年下半年收入按年持平,纯利则按年增长60%,期内中国内地业务表现持续改善,收入跌幅由上半财年的9%收窄至3%;澳洲业务经调整后经营亏损则收窄至4,000万元。麦格理维持维他奶的“跑赢大市”评级,目标价由7.4元上调至7.9元,预期严格成本管理及渠道扩张将支撑未来盈利增长。计及包装材料成本压力,该行将2027及2028财年纯利预测分别下调...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.